{"id":158168,"date":"2026-08-22T08:07:11","date_gmt":"2026-08-22T08:07:11","guid":{"rendered":"https:\/\/www.europesays.com\/sk\/158168\/"},"modified":"2026-08-22T08:07:11","modified_gmt":"2026-08-22T08:07:11","slug":"popularny-liek-na-erekciu-spajaju-s-vyssim-rizikom-glaukomu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/sk\/158168\/","title":{"rendered":"Popul\u00e1rny liek na erekciu sp\u00e1jaj\u00fa s vy\u0161\u0161\u00edm rizikom glauk\u00f3mu"},"content":{"rendered":"<p>TAJ-PEJ &#8211; Pom\u00e1ha mu\u017eom pri probl\u00e9moch s erekciou a pou\u017e\u00edva sa aj pri zv\u00e4\u010d\u0161enej prostate. Nov\u00fd rozsiahly v\u00fdskum v\u0161ak upozor\u0148uje na mo\u017en\u00e9 riziko spojen\u00e9 s tadalafilom, zn\u00e1mym najm\u00e4 pod obchodn\u00fdm n\u00e1zvom Cialis. Mu\u017ei, ktor\u00fdm ho lek\u00e1ri predpisovali, mali \u010dastej\u0161ie diagnostikovan\u00fd glauk\u00f3m. Vedci v\u0161ak zd\u00f4raz\u0148uj\u00fa, \u017ee v\u00fdsledky nedokazuj\u00fa, \u017ee liek ochorenie priamo sp\u00f4sobuje.<\/p>\n<p>\t\t\t\tTakmer 74-tis\u00edc mu\u017eov<\/p>\n<p>Tadalafil patr\u00ed medzi takzvan\u00e9 inhib\u00edtory PDE5, podobne ako sildenafil, zn\u00e1my najm\u00e4 pod obchodn\u00fdm n\u00e1zvom Viagra. Okrem lie\u010dby erektilnej dysfunkcie sa tadalafil pou\u017e\u00edva aj pri pr\u00edznakoch nezhubn\u00e9ho zv\u00e4\u010d\u0161enia prostaty, napr\u00edklad \u010dastom nutkan\u00ed na mo\u010denie \u010di slabom pr\u00fade mo\u010du.<\/p>\n<p>Pr\u00e1ve na tak\u00e9to dlhodobej\u0161ie u\u017e\u00edvanie sa zamerali vedci z National Taiwan University Hospital a \u010fal\u0161\u00edch pracov\u00edsk. V\u00fdsledky zverejnili v odbornom \u010dasopise British Journal of Ophthalmology, informoval New York Post.<\/p>\n<p>V\u00fdskumn\u00edci analyzovali zdravotn\u00e9 \u00fadaje 73 854 mu\u017eov vo veku najmenej 40 rokov. Polovica mala predp\u00edsan\u00fd tadalafil alebo in\u00fd liek z rovnakej skupiny, druh\u00e1 polovica tieto pr\u00edpravky neu\u017e\u00edvala. Obe skupiny vedci porovnali aj pod\u013ea veku, faj\u010denia a viacer\u00fdch ochoren\u00ed, ktor\u00e9 mohli v\u00fdsledky ovplyvni\u0165.<\/p>\n<p>Riziko bolo vy\u0161\u0161ie<\/p>\n<p>V\u00fdsledky uk\u00e1zali rozdiel. Mu\u017ei s predp\u00edsan\u00fdm tadalafilom mali v porovnan\u00ed s kontrolnou skupinou o 22 percent vy\u0161\u0161ie riziko diagn\u00f3zy glauk\u00f3mu. Pri prim\u00e1rnom glauk\u00f3me s otvoren\u00fdm uhlom, ktor\u00fd je jeho naj\u010dastej\u0161ou formou, bolo riziko vy\u0161\u0161ie o 33 percent.<\/p>\n<p>O 32 percent \u010dastej\u0161ie sa u nich objavila aj o\u010dn\u00e1 hypertenzia, teda zv\u00fd\u0161en\u00fd vn\u00fatroo\u010dn\u00fd tlak, ktor\u00fd patr\u00ed medzi v\u00fdznamn\u00e9 rizikov\u00e9 faktory glauk\u00f3mu.<\/p>\n<p>Glauk\u00f3m po\u0161kodzuje zrakov\u00fd nerv a patr\u00ed medzi z\u00e1va\u017en\u00e9 pr\u00ed\u010diny straty zraku. Zradn\u00fd je najm\u00e4 t\u00fdm, \u017ee v po\u010diato\u010dn\u00fdch \u0161t\u00e1di\u00e1ch \u010dasto nesp\u00f4sobuje v\u00fdrazn\u00e9 pr\u00edznaky. Po\u0161kodenie zraku, ktor\u00e9 u\u017e ochorenie sp\u00f4sobilo, sa pritom ned\u00e1 zvr\u00e1ti\u0165.<\/p>\n<p>Cialis nevyhadzujte<\/p>\n<p>Pr\u00e1ve tu je v\u0161ak potrebn\u00e9 brzdi\u0165 dramatick\u00fd titulok New York Postu, pod\u013ea ktor\u00e9ho popul\u00e1rne lieky na erekciu m\u00f4\u017eu \u010dloveka pripravi\u0165 o zrak.<\/p>\n<p>\u0160t\u00fadia bola observa\u010dn\u00e1. Dok\u00e1zala s\u00favislos\u0165 medzi u\u017e\u00edvan\u00edm tadalafilu a vy\u0161\u0161\u00edm v\u00fdskytom glauk\u00f3mu, nie to, \u017ee tadalafil ochorenie sp\u00f4sobil. Autori navy\u0161e prizn\u00e1vaj\u00fa viacer\u00e9 obmedzenia v\u00fdskumu.<\/p>\n<p>Sami preto v\u00fdslovne upozor\u0148uj\u00fa, \u017ee ich v\u00fdsledky nie s\u00fa d\u00f4vodom na z\u00e1kaz alebo automatick\u00e9 vysadenie tadalafilu.<\/p>\n<p>Odpor\u00fa\u010daj\u00fa sk\u00f4r zv\u00fd\u0161en\u00fa pozornos\u0165 pri dlhodobom u\u017e\u00edvan\u00ed. O\u010dn\u00e9 kontroly m\u00f4\u017eu by\u0165 vhodn\u00e9 najm\u00e4 pre mu\u017eov, ktor\u00ed u\u017e maj\u00fa zv\u00fd\u0161en\u00fd vn\u00fatroo\u010dn\u00fd tlak, glauk\u00f3m v rodine, v\u00fdrazn\u00fa kr\u00e1tkozrakos\u0165 alebo in\u00e9 rizikov\u00e9 faktory.<\/p>\n<p>V\u00fdsledky navy\u0161e nadv\u00e4zuj\u00fa na star\u0161ie ot\u00e1zky t\u00fdkaj\u00face sa liekov na erekciu a zraku. Pri inhib\u00edtoroch PDE5 sa u\u017e v minulosti sk\u00famala mo\u017en\u00e1 s\u00favislos\u0165 so vz\u00e1cnym po\u0161koden\u00edm zrakov\u00e9ho nervu zn\u00e1mym ako NAION. V\u00fdsledky predch\u00e1dzaj\u00facich \u0161t\u00fadi\u00ed v\u0161ak neboli jednozna\u010dn\u00e9.<\/p>\n<p>Nov\u00fd v\u00fdskum preto neprin\u00e1\u0161a d\u00f4vod na paniku. Prin\u00e1\u0161a v\u0161ak \u010fal\u0161\u00ed argument, pre\u010do by mu\u017ei u\u017e\u00edvaj\u00faci tadalafil dlhodobo \u2013 najm\u00e4 t\u00ed s rizikov\u00fdmi faktormi \u2013 nemali zab\u00fada\u0165 ani na svoje o\u010di.<\/p>\n","protected":false},"excerpt":{"rendered":"TAJ-PEJ &#8211; Pom\u00e1ha mu\u017eom pri probl\u00e9moch s erekciou a pou\u017e\u00edva sa aj pri zv\u00e4\u010d\u0161enej prostate. Nov\u00fd rozsiahly v\u00fdskum&hellip;\n","protected":false},"author":2,"featured_media":158169,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[8],"tags":[46397,46399,3500,33,12315,43,40,42,36,46398,5342,50,5343,49,48],"class_list":["post-158168","post","type-post","status-publish","format-standard","has-post-thumbnail","category-svet","tag-erekcia","tag-glaukom","tag-liek","tag-news","tag-oci","tag-sk","tag-slovak","tag-slovencina","tag-spravy","tag-strata-zraku","tag-studia","tag-svet","tag-vedci","tag-world","tag-world-news"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/117138138480908592","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/158168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=158168"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/158168\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/158169"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=158168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=158168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=158168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}